+547.9%
IREN vs THC
+413.3%
+134.6%
-76.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +20.0% | -1.1% | +21.1% | +20.1% |
| 7D | -9.6% | +3.7% | -13.3% | -9.7% |
| 30D | -44.1% | +9.0% | -53.1% | -44.3% |
| 3M | -42.9% | +10.4% | -53.3% | -43.3% |
| 6M | -64.5% | +45.7% | -110.2% | -65.9% |
| YTD | -42.7% | +42.6% | -85.3% | -45.0% |
| 1Y | -67.7% | +38.8% | -106.4% | -68.9% |
| 3Y | +547.9% | +418.8% | +129.1% | +395.7% |
| All | +547.9% | +413.3% | +134.6% | +395.7% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling